BAM-002 in NSCLC (Novelos Therapeutics) Describes the Phase II trial of BAM-002 for NSCLC that compares BAM-002 plus chemotherapy to chemotherapy alone. Notes encouraging results of a previous (controlled) trial conducted in Russia.
